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The conventional Clock Drawing Test (cCDT) is a rapid and inexpensive screening tool
for detection of moderate and severe dementia. However, its usage is limited due to
poor diagnostic accuracy especially in patients with mild cognitive impairment (MCI).
The diagnostic value of a newly developed digital Clock Drawing Test (dCDT) was
evaluated and compared with the cCDT in 20 patients with early dementia due to
AD (eDAT), 30 patients with amnestic MCI (aMCI) and 20 cognitively healthy controls
(HCs). Parameters assessed by dCDT were time while transitioning the stylus from one
stroke to the next above the surface (i.e., time-in-air), time the stylus produced a visible
stroke (i.e., time-on-surface) and total-time during clock drawing. Receiver-operating
characteristic (ROC) curves were calculated and logistic regression analyses have
been conducted for statistical analysis. Using dCDT, time-in-air was significantly
increased in eDAT (70965.8 ms) compared to aMCI (54073.7 ms; p = 0.027) and HC
(32315.6 ms; p < 0.001). In addition, time-in-air was significantly longer in patients with
aMCI compared to HC (p = 0.003), even in the aMCI group with normal cCDT score
(54141.8 ms; p < 0.001). Time-in-air using dCDT allowed discrimination of patients
with aMCI from HCs with a sensitivity of 81.3% and a specificity of 72.2% while cCDT
scoring revealed a sensitivity of 62.5% and a specificity of 83.3%. Most interestingly,
time-in-air allowed even discrimination of aMCI patients with normal cCDT scores (80%
from all aMCI patients) from HCs with a clinically relevant sensitivity of 80.8% and a
specificity of 77.8%. A combination of dCDT variables and cCDT scores did not improve
the discrimination of patients with aMCI from HC. In conclusion, assessment of time-in-
air using dCDT yielded a higher diagnostic accuracy for discrimination of aMCI patients
from HCs than the use of cCDT even in those aMCI patients with normal cCDT scores.
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Modern digitizing devices offer the opportunity to measure subtle changes of visuo-
constructive demands and executive functions that may be used as a fast and easy to
perform screening instrument for the early detection of cognitive impairment in primary
care.
Keywords: early Alzheimer’s disease, amnestic mild cognitive impairment, screening, clock drawing test, online-
drawing
INTRODUCTION
The number of cognitively impaired individuals will increase
dramatically as the elderly population increases. Thus, the
issue of screening for dementia and cognitive impairment will
become increasingly important. However, currently nearly 50%
of dementia cases are not diagnosed (Boustani et al., 2003;
Mukadam et al., 2015). In addition, there is a considerable delay
in the diagnosis of dementia which may reduce the effectivity
of available treatments (Boustani et al., 2003; Carpentier et al.,
2010; Rapp, 2014; Akl et al., 2015). Furthermore, currently
availablemeasures for diagnosis of dementia are time-consuming
(psychometric testing), invasive (cerebrospinal fluid (CSF)
examination) or expensive (neuro-imaging). Thus, there is an
urgent need to develop fast and easily to perform, non-invasive
and non-expensive diagnostic measures able to accurately detect
people with cognitive impairment and dementia in the earlier
stages to provide them further diagnostics (i.e., CSF examination
and/or neuro-imaging) in case of positive screening results.
This may be beneficial to allow earlier onset of available
treatment medications and to allow more careful planning of
financial and support systems when the patients are still in a
position to make their wishes known (Solomon and Murphy,
2005).
The basic purpose of cognitive screening tests is to indicate
the likelihood of genuine cognitive impairment, inferred from
the relationship of the patient’s score to reference norms. A
very impaired score (along with supporting history) may lead a
physician to make a diagnosis without further investigation; a
borderline score may prompt referral for specialist assessment
(e.g., at a memory clinic), where available. The success of a
particular screening tool for this purpose lies in its statistical
robustness—ideally, high sensitivity and specificity along with a
high positive predictive value in a population with a relevant base
rate of impairment.
In this context the conventional Clock Drawing Test
(cCDT) is one of the most widely used tests for screening
cognitive impairment and dementia that has been well accepted
among clinicians and patients for its ease of use and short
administration time (Shulman, 2000). The cCDT is a valuable
cognitive screening test for both quantitative and qualitative
assessment of a variety of cognitive functions, including
selective and sustained attention, auditory comprehension,
verbal working memory, numerical knowledge, visual memory
and reconstruction, visuospatial abilities, on-demand motor
execution (praxis) and executive function (Shulman et al., 1986).
The ease of use and broad range of cognitive abilities required
for successful completion of the cCDT have made this an
effective and increasingly popular cognitive screening instrument
among researchers and clinicians, however interpretation of the
cCDT necessitates consideration of the wide range of cognitive
abilities that are assessed by this test (Frey and Arciniegas,
2011). Furthermore, although there is great interest in the
cCDT as a cognitive screening tool, there are multiple cCDT
administration and scoring systems with no consensus on
which system produces the most valid results while remaining
user friendly (Ricci et al., 2016). Additionally, while there is
a general agreement in considering the cCDT as a useful
test to detect moderate and severe dementia (Pinto and
Peters, 2009), its utility in distinguishing patients with mild
cognitive impairment (MCI) or mild dementia is still debated
(Seigerschmidt et al., 2002; Pinto and Peters, 2009; Ehreke et al.,
2011).
cCDT demands like drawing and handwriting are complex
human activities that entail an intricate blend of cognitive,
kinesthetic and perceptual-motor components, including visual
perception, memory and reconstruction, visuospatial abilities,
on-demandmotor planning and execution (praxis) and executive
function (Forbes et al., 2004; Yan et al., 2008; Forbes-Mckay
et al., 2014). Thus, these characteristics of the drawing process
suggest that it might be sensitive to impairments in cognitive
functioning, and thus assessments of drawings might facilitate
the diagnosis of such impairments (Schmitt et al., 2009). Indeed,
deficits in these areas reflect possible frontal and temporoparietal
disturbances that are often exhibited in AD (Samton et al., 2005),
and that may not easily be detected by commonly-used cognitive
screening tests such as the Mini-Mental State Examination
(MMSE; Brodaty and Moore, 1997). Furthermore, disturbances
in the sensory-motor system due to neuropathological changes
may contribute to reduced levels of motor performance
associated with Alzheimer’s disease (AD; Dick et al., 1995;
Walker et al., 1997; Petersen et al., 2000; Pennanen et al.,
2004). However, although there may be some generalizations
about what can be considered a normal clock, it is important
to note that if a subject’s clock shows an error, it does not
necessarily mean that the person is impaired. Likewise, if a
clock drawing falls into the range of ‘‘normal’’ performance,
this does not necessarily implicate that the subject is cognitively
normal.
Modern digitizing tablets not only gather the x-y coordinates
that describe the movement of the writing device as it changes
its position during handwriting or drawing, but they can also
take into account information collected when the writing device
is not exerting pressure on the writing surface (i.e., in-air
movements performed by the hand while transitioning from
one stroke to the next; during these movements the writing
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device exerts no pressure on the surface). Recent experimental
results based on pen pressure and in-air movements appear to
be significantly different for patient with early AD compared to
healthy control (HC) individuals (Faundez-Zanuy et al., 2014).
More recently, the diagnostic value of a tablet-based drawing task
(i.e., drawing three-dimensional house) for the discrimination
of patients with amnestic MCI (aMCI) or early dementia
of Alzheimer-type (eDAT) from HC could be demonstrated
(Müller et al., 2017). In this study i.e., time-in-air differed
significantly between patients with aMCI, eDAT and HCs
demonstrating an excellent sensitivity and a moderate specificity
to discriminate aMCI subjects from normal elderly and an
excellent sensitivity and specificity to discriminate patients
affected by mild AD from healthy individuals (Müller et al.,
2017).
Other studies reported increased writing thickness and
pressure of the pen in patients with mild to moderate dementia
due to AD compared with HCs (Labarge et al., 1992).
Moreover, patients who were either apractic from an early
stage of AD or who switched to being apractic as the disease
progressed had a faster rate of decline than those patients
who remained able to complete drawing tasks (Smith et al.,
2001). Thus, patients who were unable to complete the praxis
task from an early stage had a worse prognosis than those
who maintained this ability. In line with this it was found
that handwriting difficulties were correlated with the severity
of AD and the concomitant cognitive impairment (Schröter
et al., 2003). It seems that motor skills were impaired early in
AD because they require cognitive decision making in order to
perform automatic retrieval (Croisile, 1999). Kinematical results
of circular and quick handwriting movements performed by
patients with AD, MCI and HCs showed a greater variability
in movement velocity in AD and MCI patients (Schröter et al.,
2003).
In the present study we evaluated the diagnostic value of a
newly developed digital Clock Drawing Test (dCDT) assessing
time-in-air, time-on-surface and total-time of the drawing
process in patients with aMCI, eDAT and HCs and compared
it with the diagnostic value of cCDT (Shulman, 2000).
MATERIALS AND METHODS
Participants
Our study included 70 participants (34 females and 36 males)
with a mean age of 66.9± 10.3 years. All participants were right-
hander (Oldfield, 1971), had normal or corrected-to-normal
visual acuity and sufficient hearing ability. No participants had
a physical handicap that affected his or her ability to perform
the tasks or any indication of other neurological or psychiatric
disorders unrelated to his or her diagnosis. To exclude symptoms
of depression, all participants completed the German 15-item
version of the Geriatric Depression Scale (GDS; exclusion
criterion GDS > 5; Yesavage et al., 1982). The local ethical
committee at the University Hospital of Tübingen approved the
study. All participants signed an informed consent form after
receiving a detailed explanation of the study.
Patients with aMCI or eDAT
Patients with aMCI or eDAT were recruited from the Memory
Clinic of the Department of Psychiatry and Psychotherapy at
the University Hospital of Tübingen. They underwent physical,
neurological, neuropsychological and psychiatric examinations
as well as brain imaging. Routine laboratory tests included Lues
serology and analysis of vitamin B12, folic acid and thyroid-
stimulating hormone levels.
The diagnostic criteria for eDAT were defined according
to the National Institute of Neurological and Communicative
Disorders and Stroke Alzheimer’s Disease and Related Disorders
Association (McKhann et al., 1984; Petersen et al., 2010). All of
these patients had a score of 4 on the Global Deterioration Scale
(Reisberg et al., 1982).
The diagnosis of aMCI was defined according to the Mayo
criteria (Petersen, 2004), which include the presence of a memory
complaint (corroborated by an informant), objectively impaired
memory function, intact activities of daily living and the absence
of dementia.
Healthy Control Group
HC individuals had no history of neurological or psychiatric
disease or any sign of cognitive decline, as confirmed by a clinical
interview.
Neuropsychological Assessment
All participants undergo a neuropsychological examination that
includes the German version of the modified Consortium to
Establish a Registry for Alzheimer’s Disease neuropsychological
test battery (CERAD; Morris et al., 1989) including the MMSE
(Folstein et al., 1975) and the Trail Making Test (Reitan,
1958).
The Trail Making Test part A (TMT-A) assesses psychomotor
speed operationalized by connecting as fast as possible the
numbers 1–25 in ascending order. Trail Making Test part B
(TMT-B) includes numbers (1–13) and letters (A–L) which must
be connected in an ascending alternating pattern (i.e., 1-A-2-
B-3-C, etc.) as fast as possible. As the subjects have to switch
between mental sets the TMT-B is used to assess cognitive
flexibility and reflects executive functions (Crowe, 1998; Chen
et al., 2009).
Computerized Assessment of Clock
Drawing
A Windows Surface Pro 4 digitizer and a handheld stylus pen
were used to assess drawing movements. The tablet acquires
120 samples per second including the spatial coordinates (x, y).
The spatial accuracy is 0.25 mm (resolution 267 pixels per inch).
Binary variables indicating pen-up state (i.e., 0) or pen-down
state (i.e., 1).
Time-in-air and time-on-surface are assessed in milliseconds
(ms) according to their binary coding, total-time correspond to
the time-in-air plus time-on-surface. All participants performed
the cCDT on the digitizer with a handheld stylus pen following
the instruction to draw a circle (i.e., clock face) with the numbers
in appropriate positions and to place the hands on the clock
to indicate ‘‘10 past 11 o’clock’’. The results were evaluated
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by scoring from 1 point (i.e., perfect) to 6 points (i.e., not
representative of a clock at all). A score ≥3 was considered as
impaired (Shulman, 2000).
Data Analysis
The statistical software package SPSS (version 23) was used for
data analyses. For all tests, the level of statistical significance
was set to p < 0.05. Levene’s test served to assess homogeneity
of variances. We used the Pearson chi-square test to detect
group differences in gender distribution and the nonparametric
Kruskal-Wallis test to detect group differences in cCDT and
GDS scores. Group differences in age, education and global
cognition (MMSE), TMT-A and B, time-in-air, time-on-surface
and total-time were assessed using one-way analysis of variance
(ANOVA) followed by a post hoc Tukey test. To asses group
differences in clinical and demographical variables (i.e., age, years
of education and MMSE), TMT-A and B, as well as in time-
in-air, time-on-surface and total-time between patients with
aMCI showing normal cCDT-scores (i.e., cCDT score of 1 or 2)
and healthy individuals t-tests for independent samples were
conducted. Bonferroni adjustment was used to correct for type
I errors introduced by the use of multiple tests (i.e., comparisons
for this analysis were performed at the p < 0.0062 level of
significance).
Receiver operating characteristics (ROC) curves were
established to illustrate the specificity of dCDT variables
(i.e., time-in-air, time-on-surface and total-time) as well as
cCDT scores in relation to the sensitivity in classifying HC
individuals and patients with aMCI (HCs vs. patients with
eDAT, respectively).
To evaluate the utility of the target variables in distinguishing
HCs and patients with aMCI (HCs vs. patients with eDAT,
respectively) logistic regression analyses were conducted, with
diagnostic group as the dependent variable and time-in-
air, time-on-surface, total-time and cCDT scores as the
independent variable, adjusted for age, gender and years of
education and controlled for the influence of psychomotor
speed and executive functions (i.e., TMT scores). To evaluate
diagnostic accuracy of dCDT variables in case of a subjects’
cCDT-score indicates no impairment after visual inspection
(i.e., CDT score 1 or 2) the same analyses (i.e., ROC curves
and logistic regression analyses) have been performed for
patients with aMCI showing normal cCDT scores and healthy
individuals.
In order to investigate whether the combined analysis
of time-in-air, time-on-surface, total-time and cCDT scores
would improve the discrimination of patients with aMCI
from controls in terms of sensitivity and specificity logistic
regression models were constructed in which we combined
the predictor variables. Time-in-air, time-on-surface, total-time
and cCDT scores (without cCDT scores for patients with
aMCI showing normal cCDT values and healthy individuals
respectively) were entered into a forward stepwise logistic
regression model based on significant improvement in Log
Likelihood Ratios and significance of the included variables
testing their ability to predict aMCI (with impaired cCDT
scores likewise normal cCDT scores) and HC in the derivation
cohort. Predictor variables were adjusted for age, gender and
years of education and selected for inclusion in the model if
p< 0.05.
RESULTS
Clinical and Demographic Characteristics
of the Participants
HC, aMCI and AD groups did not significantly differ in age,
education and gender distribution. Also, GDS scores were
not significantly different between groups and well below the
cut-off score of 6. As expected, a one-way ANOVA revealed
highly significant differences in MMSE scores (F(2,67) = 104.85;
p < 0.001). HC subjects had higher mean MMSE scores than
aMCI (p< 0.001) and AD patients (p< 0.001). Moreover, mean
MMSE scores of aMCI patients were higher than those of AD
patients (p < 0.001). Performance in TMT-A (F(2,67) = 12.26;
p < 0.001) as well as TMT-B (F(2,67) = 38.03; p < 0.001)
differed significantly between the groups (Table 1). Post hoc
Tukey analysis revealed that time to complete TMT-A and B
was significantly longer (indicating greater impairment) in the
eDAT group compared to HCs (TMT-A and B: p < 0.001) and
aMCI patients (TMT-A: p = 0.003; TMT-B: p < 0.001). Healthy
individuals and patients with aMCI did not differ significantly in
either TMT-A (p = 0.121) or TMT-B (p = 0.186).
Comparing healthy individuals and the aMCI group with
normal cCDT score (i.e., a cCDT score of 1 or 2) the HC
group had significantly higher mean MMSE scores compared to
patients with aMCI (p< 0.001), but they did not differ in TMT-A
or B performance, age, education and gender distribution
(Table 2).
Performance on the Clock Drawing Task in
Patients with aMCI, eDAT and Healthy
Individuals
Overall, cCDT performance differed significantly between the
groups (χ2(2) = 31.525; p < 0.001; Table 1). cCDT scores
were significantly higher (i.e., indicating greater impairment)
in patients with eDAT compared to MCI (p < 0.001) and HC
(p< 0.001) as well as in patients with aMCI compared to healthy
individuals (p = 0.009).
Analyzing the digitized variables during clock drawing, we
found a significant difference in time-in-air (F(2,67) = 15.230;
p < 0.001; Table 1). Transitioning the drawing hand from one
stroke to the next requires significantly less time in the HC
group compared to patients with aMCI (p = 0.003) and eDAT
(p < 0.001). Additionally, time-in-air in the aMCI group was
significantly shorter compared to patients with eDAT (p = 0.027).
Although a stable trend was observable time-on-surface
just failed to differ between the groups on the predetermined
significance level (F(2,67) = 3.008; p = 0.056; Table 1).
Finally, we found significant differences in total-time
(F(2,67) = 10.518; p < 0.001; Table 1). HC individuals required
significantly less time to complete clock drawing compared to the
aMCI (p = 0.005) and the eDAT group (p < 0.001). However,
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TABLE 1 | Clinical and demographic characteristics of HC individuals, patients with aMCI and patients with early dementia due to AD (eDAT).
Group p-value
HC aMCI eDAT
n 20 30 20
Age in years 66.9 (9.4) 65.3 (6.6) 69.6 (6.1) 0.368
Years of education 13.2 (3.2) 11.9 (2.7) 11.8 (3.0) 0.230
Gender (M/F) 12/8 15/15 9/11 0.624
GDS 2.7 (2.2) 2.1 (2.0) 2.4 (1.7) 0.345
MMSE 29.4 (0.6) 26.6 (1.6) 21.7 (3.4) <0.001
TMT-A 38.65 (10.8) 53.52 (24.5) 78.7 (36.7) <0.001
TMT-B 85.0 (32.0) 108.55 (54.5) 203.55 (44.2) <0.001
cCDT 1.2 (0.4) 1.9 (0.8) 2.9 (0.9) <0.001
no. CDT Score 1 (%) 16 (80.0) 11 (36.7) 2 (10.0)
no. CDT Score 2 (%) 4 (20.0) 13 (43.3) 2 (10.0)
no. CDT Score 3 (%) 0 (0.0) 6 (20.0) 11 (55.0)
no. CDT Score 4 (%) 0 (0.0) 0 (0) 5 (25.0)
Time-in-air (ms) 32315.6 (5633.8) 54073.7 (18174.9) 70965.8 (34843.6) <0.001
Time-on-surface (ms) 15712.8 (3434.5) 19332.5 (6416.9) 18233.9 (4337.8) = 0.056
Total-time (ms) 49228.4 (10358.1) 73309.4 (20952.9) 86199.8 (40226.7) <0.001
Note: Values are expressed as mean (standard deviation). n, number; HC, healthy control individuals; aMCI, amnestic mild cognitive impairment; eDAT, early Alzheimer-type
dementia; M/F, male/female; GDS, Geriatric Depression Scale (higher score indicates more severe depressive symptoms; maximum 15; scores of >5 indicates
depression); MMSE, Mini Mental State Examination; TMT, Trail Making Test (part A or B, time in seconds); cCDT, conventional Clock Drawing Test (a score ≥3 is
considered as impaired); %, percentage; ms, time in milliseconds.
patients with aMCI and eDAT did not differ significantly
(p = 0.202).
Screening Value of the Clock Drawing Task
in Patients with aMCI, eDAT and Healthy
Individuals
When the traditional scoring system of the cCDT was used
(i.e., a score ≥3 is considered as impaired) to discriminate
between the aMCI group and healthy individuals, the best
cut-off was a score of 1.5 (AUC: 0.745; p = 0.004; Figure 1)
revealing an accuracy of 70.0% with sensitivity of 62.5%
and specificity of 83.3% (Table 3). With an accuracy of
87.1% in discriminating the eDAT group and HCs a
score of 2.5 (AUC: 0.933; p < 0.001; Figure 2) on the
cCDT had a sensitivity of 90.5% and a specificity of 83.3%
(Table 3).
An accuracy of 78.0% was found when time-in-air was used
to discriminate between the aMCI group and healthy individuals
at 35588 ms (AUC: 0.880; p < 0.001; Figure 1) with sensitivity
of 81.3% and specificity of 72.2% (Table 3). Between the eDAT
group and HCs a cut-off of 39869 ms (AUC: 0.947; p < 0.001;
Figure 2) on the time-in-air score revealed an accuracy of 87.2%
with a sensitivity of 85.7% and a specificity of 88.9% (Table 3).
When total-time was used to discriminate between the aMCI
group and healthy individuals, the best cut-point was at 51187ms
TABLE 2 | Clinical and demographic characteristics of HC individuals and patients with aMCI with normal cCDT scores.
Group p-value
HC aMCI
n 20 24
Age in years 66.9 (9.4) 65.9 (8.5) =0.836
Years of education 13.2 (3.2) 12.5 (2.5) =0.170
Gender (M/F) 12/8 12/12 =0.556
MMSE 29.4 (0.6) 27.1 (1.6) <0.001
TMT-A 38.65 (10.8) 45.42 (23.8) =0.089
TMT-B 85.0 (32.0) 95.08 (35.5) =0.336
cCDT 1.2 (0.4) 1.5 (0.5) =0.031
no. CDT Score 1 (%) 16 (80.0) 11 (45.8)
no. CDT Score 2 (%) 4 (20.0) 13 (54.2)
Time-in-air (ms) 32315.6 (5633.8) 54141.8 (17428.1) <0.001
Time-on-surface (ms) 15712.8 (3434.5) 19990.1 (6836.3) = 0.011
Total-time (ms) 49228.4 (10358.1) 74133.1 (20254.3) <0.001
Note: Values are expressed as mean (standard deviation). n, number; HC, healthy control individuals; aMCI, amnestic mild cognitive impairment; M/F, male/female;
GDS, Geriatric Depression Scale (higher score indicates more severe depressive symptoms; maximum 15; scores of >5 indicates depression); MMSE, Mini Mental State
Examination; TMT, Trail Making Test (part A or B, time in seconds); cCDT, conventional Clock Drawing Test (a score ≥3 is considered as impaired); %, percentage; ms, time
in milliseconds.
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FIGURE 1 | Receiver-operating characteristic (ROC) curve analysis for
discriminating patients with amnestic mild cognitive impairment
(aMCI) from healthy control individuals (HC) using time-in-air,
time-on-surface, total-time, or conventional clock drawing test (cCDT)
scores.
total-time (AUC: 0.813; p< 0.001; Figure 1) showing an accuracy
of 68.0% with a sensitivity of 71.9% and specificity of 61.1%
(Table 3). Between the eDAT group and HCs a cut-off of
58165 ms (AUC: 0.823; p = 0.001; Figure 2) on the total-time
score had an accuracy of 76.9%, a sensitivity of 71.4% and a
specificity of 83.3% (Table 3).
As time-on-surface failed to differ between the groups
significantly this variable was excluded from further
discrimination analysis.
In the first step (model 1), time-in-air was included in the
forward stepwise logistic regression model and finally cCDT
scores (model 2). Model 2 yielded significant Odds Ratios
(95% confidence interval) for time-in-air (6.515 [6.463–6.567];
p = 0.004) and cCDT scores (4.671 [4.567–4.781]; p = 0.046).
Time-in-air (i.e., model 1) explained 27.9% of the variance
(adjusted R2 = 0.279, F(1,49) = 18.587, p < 0.001). Model 2
(i.e., time-in-air and cCDT scores) explained 35.6% of the
variance (adjusted R2 = 0.356, F(2,49) = 12.965, p < 0.001; R2
change = 0.076, F(1,47) = 5.572; p = 0.022).
Time-on-surface (p = 0.271) and total-time (p = 0.583) were
excluded from the regression model. However, with an accuracy
of 76.0% resulting from 81.3% sensitivity and 66.7% specificity,
FIGURE 2 | ROC curve analysis for discriminating patients with early
dementia due to Alzheimer’s disease (eDAT) from HC individuals using
time-in-air, time-on-surface, total-time, or cCDT scores.
the combination of time-in-air and cCDT scores did not improve
the discrimination of patients with aMCI from HCs.
Performance on the Clock Drawing Task in
Patients with aMCI Showing Normal cCDT
Scores and Healthy Controls
Between patients with aMCI (n = 24) with normal cCDT scores
(i.e., cCDT score of 1 or 2) and healthy individuals (n = 20) time-
in-air (p < 0.001), and total-time (p < 0.001) were significantly
lower in HC individuals compared to patients with aMCI. Time-
on-surface (p = 0.011) did not differ with respect to the adjusted
significance level (i.e., p< 0.0062; Table 2).
Screening Value of the Clock Drawing Task
in Patients with aMCI Showing Normal
cCDT Score and Healthy Controls
In the aMCI group with normal cCDT scores and HC time-
in-air discriminated best with an accuracy of 79.5% at a
cut-off of 36468 ms (AUC: 0.885; p < 0.001; Figure 3)
showing a sensitivity of 80.8% and a specificity of 77.8%
(Table 4).
An accuracy of 63.6% was found when time-on-surface was
used to discriminate between aMCI patients with normal cCDT
TABLE 3 | Diagnostic value of time-in-air, time-on-surface, total-time and cCDT scoring in differentiating patients with aMCI or eDAT from HC individuals
HC.
HC vs. aMCI HC vs. eDAT
Sensitivity Specificity Accuracy Sensitivity Specificity Accuracy
Time-in-air 81.3 72.2 78.0 85.7 88.9 87.2
Time-on-surface 75.0 50.0 66.0 76.2 61.1 69.2
Total-time 71.9 61.1 68.0 71.4 83.3 76.9
cCDT 62.5 83.3 70.0 90.5 83.3 87.1
HC, healthy control individuals; aMCI, amnestic mild cognitive impairment; eDAT, early dementia due to Alzheimer’s disease; cCDT, conventional Clock Drawing Test.
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FIGURE 3 | ROC curve analysis for discriminating patients with aMCI
with unimpaired cCDT scores (i.e., cCDT score 1 or 2) from HC
individuals using time-in-air, time-on-surface, or total-time.
score and HCs at a cut-point of 15803 ms (AUC: 0.744; p = 0.007;
Figure 3) with sensitivity of 65.4% and specificity of 61.1%
(Table 4).
When total-time was used to discriminate between the aMCI
group with normal CDT scores and healthy individuals, an
accuracy of 75.0%was found at 54624ms (AUC: 0.831; p< 0.001;
Figure 3) with sensitivity of 76.9% and specificity of 72.2%
(Table 4).
In order to improve the discrimination of aMCI with
normal cCDT from HC forward stepwise logistic regression
model combing time-in-air, time-on-surface and total-time
revealed significant Odds Ratio (95% confidence interval)
for time-in-air as the best predictor variable (6.858
[6.807–6.909]; p = 0.005). The combination with time-on-
surface (p = 0.221), and/or total-time (p = 0.853) did not
improve discriminative power and were excluded from the
model assumptions.
In Figures 4–7 we present clock drawing (i.e., ‘‘ten past
eleven’’) performed by a healthy individual (Figure 4),
two patients with aMCI (Figures 5, 6) and a patient with
eDAT (Figure 7). The visual inspection of the on-surfaces
curves (deep back color) of Figure 5 suggests an unimpaired
clock drawing test score. However, the visual information
provided by the in-air movements (red color) indicates
TABLE 4 | Diagnostic value of time-in-air, time-on-surface and total-time
in differentiating patients with aMCI and HC individuals with unimpaired
cCDT scores (i.e., a cCDT score of 1 or 2).
HC vs. aMCI
Sensitivity Specificity Accuracy
Time-in-air 80.8 77.8 79.5
Time-on-surface 65.4 61.1 63.6
Total-time 76.9 72.2 75.0
HC, healthy control individuals; aMCI, amnestic mild cognitive impairment.
FIGURE 4 | Unimpaired clock drawing performed by a HC individual.
On-surface curves (i.e., pen-down) are displayed in deep black color, in-air
movements are displayed in red color.
that the patient drew in-air spokes to orient spacing. In
Figures 6, 7 the minute hand points to 10 with progressive
impairment and disorganization in the eDAT patient
(i.e., Figure 7).
FIGURE 5 | Unimpaired clock drawing performed by a patient with
aMCI. On-surface curves (i.e., pen-down) are displayed in deep black color,
in-air movements are displayed in red color.
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DISCUSSION
In the present study, we examined the possible influence of aMCI
and early dementia development on alterations in movement
execution (i.e., time-in-air, time-on-surface and total-time)
during online CDT performance and whether these variables
or their combination could be used to discriminate patients in
the early course of AD (aMCI and mild dementia due to AD)
from healthy individuals.We further compared these results with
the sensitivity and specificity of the established Shulman’s CDT
scoring method for its screening value.
While the traditional CDT scoring system revealed only
poor sensitivity but excellent specificity in discriminating aMCI
patients from healthy individuals, we found excellent sensitivity
and a good specificity in discriminating these groups for in-air
movements (i.e., time-in-air). Most interestingly, even in aMCI
patients with normal cCDT score, usage of in-air trajectories
yielded excellent sensitivity and a very good specificity in
discriminating them fromhealthy individuals. This proportion of
aMCI patients with normal cCDTwas 80.0% of all aMCI patients.
Thus, these findings indicate that even if clock drawing falls into
the range of ‘‘normal’’ performance, this does not necessarily
implicate that the subject is cognitively normal.
In line with the literature (Pinto and Peters, 2009), we
obtained excellent sensitivity and specificity in distinguishing
patients affected by eDAT from healthy individuals using the
traditional CDT scoring system (Seigerschmidt et al., 2002; Pinto
and Peters, 2009; Ehreke et al., 2011). However, time-in-air
while performing clock drawing also demonstrated an excellent
sensitivity and specificity to discriminate patients with eDAT
from HCs.
FIGURE 6 | Impaired clock drawing performed by a patient with aMCI.
On-surface curves (i.e., pen-down) are displayed in deep black color, in-air
movements are displayed in red color.
Time-on-surface failed to differ between patients who are at
risk of developing AD dementia (i.e., patients with aMCI) or are
in the earliest stage of AD dementia (i.e., patients with eDAT)
from healthy individuals. Furthermore, time to complete the
whole CDT task (i.e., total-time) did not differ between patients
with aMCI and eDAT. Thus, the variable best for use in screening
for cognitive impairment and dementia is reflected in (non-
visible) prolonged in-air trajectories.
The combined analysis of dCDT and cCDT variables did not
improve the discrimination of patients with aMCI from controls
in terms of sensitivity and specificity. Likewise, combining dCDT
variables did not enhance diagnostic value in discriminating
aMCI patients with unimpaired clock drawing performance from
healthy individuals due to a lack of high diagnostic accuracy of
total-time and time-on-surface.
A complex visuomotor task (e.g., clock drawing) requires the
integration of cognitive information into amovement in the form
of rules for guiding action (Smith et al., 2001). Thus, to perform
clock drawing successfully it demands—apart of visual memory
and reconstruction, and visuospatial abilities—executive
functions (Shulman et al., 1986; Croisile, 1999; Forbes et al.,
2004; Yan et al., 2008; Forbes-Mckay et al., 2014). Prolonged
in-air trajectories might reflect impaired decision making due to
frontal and temporoparietal disturbances that are often exhibited
in the early course of AD and even in patients with aMCI
(Samton et al., 2005; Zheng et al., 2012; Blanco Martín et al.,
2016) and these interfere with cCDT demands like on-demand
motor planning, execution (praxis) and executive function
(Forbes et al., 2004; Yan et al., 2008; Forbes-Mckay et al.,
2014). According to this we found significant impairment in
TMT-B performance in our eDAT individuals compared to the
other groups that might be most likely ascribed to increased
FIGURE 7 | Impaired clock drawing performed by a patient with eDAT.
On-surface curves (i.e., pen-down) are displayed in deep black color, in-air
movements are displayed in red color.
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deterioration in cognitive flexibility and executive functions
(Crowe, 1998; Chen et al., 2009).
It is possibly due to the investigated subgroup of patients
with an amnestic syndrome that there were—as expected—no
significant differences in TMT-A and B performance between
aMCI patients and HCs. However, between HCs and aMCI there
were slight but non significant increased TMT-A and B scores
observable. Thus, our data suggest that in contrast to time-in-air
assessed with the dCDT, TMT-B might not be sensitive enough
to assess cognitive processes captured by dCDT as early as on
a subclinical level in aMCI populations (Buckner, 2004; Zheng
et al., 2012). Indeed, dCDT demands seem to be much more
complex than TMT-B requirements as dCDT impairments seem
to bemainly determined by a reduced access to semanticmemory
about the appearance and functionality of a clock (i.e., semantic
memory; Leyhe et al., 2009). However, the early detection of
executive malfunction is of great interest as in line with our
findings recent results suggest that patients with aMCI might
additionally exhibit dysexecutive syndrome even in early stages
that interfere with autonomy demands of these patients (Zheng
et al., 2012; Blanco Martín et al., 2016).
The measurable discrepancies in the quality of movement
execution between aMCI and HCs as well as in patients with
eDAT andHCs have important clinical implications. Using a fine
motor task such as drawing, the presented investigation supports
the idea of using additional movement measures like time-in-air
as an alternative diagnostic tool to enhance accuracy especially
in those subjects with normal cCDT performance, indicating no
cognitive impairment after visual inspection. Thus, the digitized
assessment of one’s non-visible time-in-air movements can be
used as supplementary information in identifying individuals in
the predementia stage of AD.
A limitation of the presented study is the relatively small
sample sizes of cognitively impaired subjects that may restrict
validity and reliability of our conclusions. Additionally, the
CDT (conventional or digital) assesses a variety of cognitive
functions and thus does not allow conclusion which domain
is affected. Further assessments are required to allow a valid
interpretation of the results obtained by the CDT. Additionally,
for or a more comprehensive use of this novel technique for
screening purposes the implementation of additional features
(e.g., assessment of velocity, pressure, writing thickness) might be
potential and should be investigated in a broader clinical setting.
Examination of fine motor control such as drawing,
contributes to the understanding of the full range of impairments
displayed by patients with prominent memory dysfunction.
The drawing task used in this study is easy to applicate by
clinicians, the apparatus of digitizer is cost-effective and reliable,
the computer software is user-friendly and customizable allowing
its application as screening test for cognitive impairment in the
context of AD in a broader clinical setting.
In conclusion, assessment of time-in-air using dCDT yielded
a higher diagnostic accuracy for discrimination of aMCI patients
from HC (78.0%) than the use of the traditional clock drawing
(i.e., cCDT) scoring system (70.0%). Even in those a MCI
patients with normal cCDT scores, assessment of time-in-air
using dCDT yielded a clinically relevant diagnostic accuracy
of 79.5%. Modern digitizing devices offer the opportunity to
measure a broad range of visuo-constructive abilities that may
be used as a fast and easy to perform screening instrument for
the early and accurate detection of cognitive impairment in the
context of AD.
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